Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.73 |
| ▸ | ENPP2 | Q13822 | 7/20 | 0.56 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.47 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.46 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.44 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.44 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.40 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6808077 | 1.00 | FUT8 (0.73) | FUT8ENPP2PRMT1CYP1A2CYP2C9 | |
| SCHEMBL3697366 | 1.00 | FUT8 (0.73) | FUT8ENPP2PRMT1CYP1A2CYP2C9 | |
| SCHEMBL10782745 | 0.94 | FUT8 (0.70) | FUT8ENPP2PRMT1CYP1A2CYP2C9 | |
| SCHEMBL10782738 | 0.94 | FUT8 (0.70) | FUT8ENPP2PRMT1CYP1A2CYP2C9 | |
| SCHEMBL13881024 | 0.90 | FUT8 (0.71) | FUT8ENPP2PRMT1CYP1A2CYP2C9 | |
| SCHEMBL8114946 | 0.90 | FUT8 (0.90) | FUT8ENPP2PRMT1CYP1A2CYP2C9 | |
| SCHEMBL8072638 | 0.90 | FUT8 (0.90) | FUT8ENPP2PRMT1CYP1A2CYP2C9 | |
| SCHEMBL6808069 | 0.87 | FUT8 (0.56) | FUT8ENPP2PRMT1CYP2C9MAPK1 | |
| SCHEMBL29385758 | 0.87 | FUT8 (0.56) | FUT8ENPP2PRMT1CYP2C9MAPK1 | |
| SCHEMBL7197090 | 0.86 | FUT8 (0.72) | FUT8ENPP2PRMT1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1373868-B1 | IMPROVED AFFINITY MATRICES WITH ENHANCED VISIBILITY FOR MOLECULAR PULL-DOWN AND IMMUNOPRECIPITATION APPLICATIONS | SIGMA ALDRICH CO LLC (US) | 2015-05-20 | — | — | EP | claimed |
| EP-1373868-A4 | IMPROVED AFFINITY MATRICES WITH ENHANCED VISIBILITY FOR MOLECULAR PULL-DOWN AND IMMUNOPRECIPITATION APPLICATIONS | SIGMA ALDRICH CO (US) | 2006-11-29 | — | — | EP | claimed |
| US-6887377-B2 | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | SIGMA-ALDRICH CO. (US) | 2005-05-03 | — | — | US | claimed |
| EP-1373868-A1 | IMPROVED AFFINITY MATRICES WITH ENHANCED VISIBILITY FOR MOLECULAR PULL-DOWN AND IMMUNOPRECIPITATION APPLICATIONS | Sigma-Aldrich Co. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20020108908-A1 | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | SIGMA-ALDRICH CO. | 2002-08-15 | — | — | US | claimed |
| WO-2002061406-A1 | IMPROVED AFFINITY MATRICES WITH ENHANCED VISIBILITY FOR MOLECULAR PULL-DOWN AND IMMUNOPRECIPITATION APPLICATIONS | SIGMA-ALDRICH CO. (US) | 2002-08-08 | — | — | WO | claimed |
| EP-1373868-B1 | IMPROVED AFFINITY MATRICES WITH ENHANCED VISIBILITY FOR MOLECULAR PULL-DOWN AND IMMUNOPRECIPITATION APPLICATIONS | SIGMA ALDRICH CO LLC (US) | 2015-05-20 | — | — | EP | disclosed |
| US-8367823-B2 | Colorants based N-halamines compositions and method of making and using | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-02-05 | — | — | US | disclosed |
| EP-2201069-A2 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | Board of Regents, The University of Texas System (US) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009039180-A2 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-03-26 | — | — | WO | disclosed |
| US-20090074825-A1 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-03-19 | — | — | US | disclosed |
| US-7438806-B2 | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | SIGMA-ALDRICH CO. (US) | 2008-10-21 | — | — | US | disclosed |
| US-20070048800-A1 | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | SIGMA-ALDRICH CO. (US) | 2007-03-01 | — | — | US | disclosed |
| US-20020108908-A1 | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications | SIGMA-ALDRICH CO. | 2002-08-15 | — | — | US | disclosed |
| WO-2002061406-A1 | IMPROVED AFFINITY MATRICES WITH ENHANCED VISIBILITY FOR MOLECULAR PULL-DOWN AND IMMUNOPRECIPITATION APPLICATIONS | SIGMA-ALDRICH CO. (US) | 2002-08-08 | — | — | WO | disclosed |
| US-6022384-A | Negative dyes and coloration process using them | ZENECA LIMITED (GB) | 2000-02-08 | — | — | US | disclosed |
| US-5968208-A | Negative dyes and coloration process using them | ZENECA LIMITED (GB) | 1999-10-19 | — | — | US | disclosed |
| EP-0876430-A1 | NEGATIVE DYES AND COLORATION PROCESS USING THEM | ZENECA LIMITED (GB) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997019137-A1 | NEGATIVE DYES AND COLORATION PROCESS USING THEM | ZENECA LIMITED (GB) | 1997-05-29 | — | — | WO | disclosed |
| US-4145340-A | WATER-SOLUBLE REACTIVE MONOAZO DYE CONTAINING A NONYLPHENOXY, CHLOROTRIAZINE GROUP | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074825-A1 | COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING | TYR, MPO, NISCH | FUT8 651/4885ENPP2 3851/4885PRMT1 949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.